Liminatus Pharma, Inc. (LIMN)
0.1894
0.00 (0.00%)
USD |
NASDAQ |
May 19, 10:56
Liminatus Pharma EPS Diluted (Quarterly) : -0.0312 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Oruka Therapeutics, Inc. | -0.5767 |
| MapLight Therapeutics, Inc. | -1.342 |
| Kailera Therapeutics, Inc. | -- |
| Veracyte, Inc. | 0.353 |
| Insight Molecular Diagnostics, Inc. | -0.1243 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.124M |
| Total Expenses (Quarterly) | 1.124M |
| Enterprise Value | 7.931M |
| Earnings Yield | -208.9% |
| Normalized Earnings Yield | -114.68 |